Tech Company Financing Transactions
E-Scape Bio Funding Round
On 7/13/2017, E-Scape Bio raised $63 million in Series A financing from OrbiMed, Johnson & Johnson Development Corporation and Lilly Asia Ventures.
Transaction Overview
Company Name
Announced On
7/13/2017
Transaction Type
Venture Equity
Amount
$63,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4000 Shoreline Ct. 400
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
E-Scape Bio is a biopharmaceutical company focused on the discovery and development of small-molecule drugs to treat genetically-defined subpopulations in neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Julie Smith
Chief Financial Officer
Anthony Rimac
Chief Medical Officer
Carrolee Barlow
VP - R & D
Ann Kapoun
Browse more venture capital transactions:
Prev: 7/13/2017: Sightbox venture capital transaction
Next: 7/13/2017: Care/of venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs